WO2011154830A3 - Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa - Google Patents
Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa Download PDFInfo
- Publication number
- WO2011154830A3 WO2011154830A3 PCT/IB2011/001415 IB2011001415W WO2011154830A3 WO 2011154830 A3 WO2011154830 A3 WO 2011154830A3 IB 2011001415 W IB2011001415 W IB 2011001415W WO 2011154830 A3 WO2011154830 A3 WO 2011154830A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- phosphodiesterase inhibitors
- transmucosal administration
- pharmaceutical form
- relates
- methylpiperazine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a una nueva forma farmacéutica de INHIBIDORES DE LA FOSFODIESTERASA para administración transmucosa. Más particularmente, la presente invención se refiere a una composición farmacéutica líquida de tipo liposomal de INHIBIDORES DE LA FOSFODIESTERASA que contiene citrato de 1 - ((3 - (6,7 - dihidro - 1 - metil - 7 - oxo - 3 - propil - 1 H-pirazolo (4,3 - d) pirimidin - 5 - il) - 4 - etoxifenil) sulfonil) - 4- metilpiperazina, como agente activo asociado con uno o más excipientes farmacéuticamente aceptables.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2012014237A MX2012014237A (es) | 2010-06-08 | 2011-06-03 | Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CO10068719 | 2010-06-08 | ||
CO10068719A CO6280050A1 (es) | 2010-06-08 | 2010-06-08 | Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011154830A2 WO2011154830A2 (es) | 2011-12-15 |
WO2011154830A3 true WO2011154830A3 (es) | 2012-03-01 |
Family
ID=44084021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2011/001415 WO2011154830A2 (es) | 2010-06-08 | 2011-06-03 | Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa |
Country Status (3)
Country | Link |
---|---|
CO (1) | CO6280050A1 (es) |
MX (1) | MX2012014237A (es) |
WO (1) | WO2011154830A2 (es) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000051572A1 (en) * | 1999-03-03 | 2000-09-08 | Elan Pharma International Ltd. | Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions |
US20020004498A1 (en) * | 1997-10-28 | 2002-01-10 | Doherty Paul C. | Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
WO2002049617A2 (en) * | 2000-12-20 | 2002-06-27 | Biozone Laboratories, Inc. | Self forming, thermodynamically stable liposomes and their applications |
CN101269212A (zh) * | 2008-04-30 | 2008-09-24 | 上海麟翔生物技术有限公司 | 一种可吞咽的漱口液 |
US20090324698A1 (en) * | 2004-10-18 | 2009-12-31 | Polymun Scientific Immunbiologische Forschung Gmbh | Liposomal composition comprising an active ingredient for relaxing smooth muscle, the production of this composition and the therapeutic use thereof |
-
2010
- 2010-06-08 CO CO10068719A patent/CO6280050A1/es not_active Application Discontinuation
-
2011
- 2011-06-03 WO PCT/IB2011/001415 patent/WO2011154830A2/es active Application Filing
- 2011-06-03 MX MX2012014237A patent/MX2012014237A/es not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020004498A1 (en) * | 1997-10-28 | 2002-01-10 | Doherty Paul C. | Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
WO2000051572A1 (en) * | 1999-03-03 | 2000-09-08 | Elan Pharma International Ltd. | Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions |
WO2002049617A2 (en) * | 2000-12-20 | 2002-06-27 | Biozone Laboratories, Inc. | Self forming, thermodynamically stable liposomes and their applications |
US20090324698A1 (en) * | 2004-10-18 | 2009-12-31 | Polymun Scientific Immunbiologische Forschung Gmbh | Liposomal composition comprising an active ingredient for relaxing smooth muscle, the production of this composition and the therapeutic use thereof |
CN101269212A (zh) * | 2008-04-30 | 2008-09-24 | 上海麟翔生物技术有限公司 | 一种可吞咽的漱口液 |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Database accession no. 2008-M66480[75] * |
Also Published As
Publication number | Publication date |
---|---|
MX2012014237A (es) | 2013-01-18 |
WO2011154830A2 (es) | 2011-12-15 |
CO6280050A1 (es) | 2011-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015010971A (es) | Derivado novedoso de pirazol. | |
EA201201263A1 (ru) | Фармацевтическая композиция, содержащая этексилат дабигатрана | |
MX2010010647A (es) | Proceso para preparar formulaciones de dabigatran para administracion oral. | |
WO2009024611A3 (en) | 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use | |
TN2012000371A1 (en) | Pyrazole compounds as crth2 antagonists | |
SG194756A1 (en) | Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids | |
WO2007014124A3 (en) | High drug load formulations and dosage forms | |
TN2013000257A1 (en) | Immunosuppressant formulations | |
WO2009084021A3 (en) | Ophthalmic composition comprising a prostaglandin | |
EA201201202A1 (ru) | Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана | |
WO2007090661A3 (en) | Active substance combination comprising azolylcarbinol compounds | |
WO2010049449A3 (en) | Novel salts of sunitinib | |
MX363699B (es) | Producto de comicronizacion que comprende acetato de ulipristal. | |
WO2009060952A1 (ja) | 新規製剤 | |
WO2014016754A3 (en) | Pharmaceutical compositions of proton pump inhibitor | |
JO3587B1 (ar) | أشكال جرعات بينداموستين عن طريق الفم | |
WO2007009691A3 (en) | Combination of substituted pyrazolines and anti -addictive agent | |
MX2021014830A (es) | Conjugados de compuestos que comprenden nitrogeno heteroaromatico donador de pares de electrones pi. | |
WO2008039894A3 (en) | Atorvastatin pharmaceutical compositions | |
TW200800977A (en) | A new salt | |
MX2016008729A (es) | Composicion farmaceutica que contiene clomipramina y metodo de preparacion de la misma. | |
WO2013188465A3 (en) | Treating drug addiction and preventing drug relapse | |
WO2005097192A3 (en) | Active substance combination of a carbinol compound and an opioid | |
WO2011154830A3 (es) | Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa | |
WO2010029093A3 (en) | Compositions for percutaneous administration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2012/014237 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11792018 Country of ref document: EP Kind code of ref document: A2 |